NovoLog PenFill and Rituximab and hyaluronidase human, recombinant Subcutaneous

• Generic Name: insulin aspart
• Dosage Forms: n.a.
• Other Brand Names: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch

Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. NovoLog PenFill is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours.

NovoLog PenFill is used to improve blood sugar control in adults and children with diabetes mellitus. NovoLog PenFill is sometimes used together with a long-acting or intermediate-acting insulin.

NovoLog PenFill may also be used for purposes not listed in this medication guide.

• Generic Name: hyaluronidase / rituximab
• Dosage Forms: n.a.
• Other Brand Names: Rituxan Hycela

Rituximab and hyaluronidase human, recombinant combination injection is used alone or together with other cancer medicines to treat follicular lymphoma and chronic lymphocytic leukemia (CLL). It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not received previous treatment.

Rituximab and hyaluronidase human, recombinant combination injection is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.

Rituximab and hyaluronidase human, recombinant is to be given only by or under the direct supervision of your doctor.